These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36688500)

  • 1. "Double-hit" ineffective erythropoiesis-concurrent β-thalassemia with α-gene triplication and myelodysplastic syndrome with SF3B1 mutation.
    Chen PH; Gorshein E; Tormey C; Siddon AJ; Perincheri S
    Am J Hematol; 2023 Jun; 98(6):984-988. PubMed ID: 36688500
    [No Abstract]   [Full Text] [Related]  

  • 2. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
    Zhu Y; Li X; Chang C; Xu F; He Q; Guo J; Tao Y; Liu Y; Liu L; Shi W
    Leuk Res; 2016 May; 44():8-16. PubMed ID: 26970172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.
    Obeng EA; Chappell RJ; Seiler M; Chen MC; Campagna DR; Schmidt PJ; Schneider RK; Lord AM; Wang L; Gambe RG; McConkey ME; Ali AM; Raza A; Yu L; Buonamici S; Smith PG; Mullally A; Wu CJ; Fleming MD; Ebert BL
    Cancer Cell; 2016 Sep; 30(3):404-417. PubMed ID: 27622333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS.
    Huang Y; Hale J; Wang Y; Li W; Zhang S; Zhang J; Zhao H; Guo X; Liu J; Yan H; Yazdanbakhsh K; Huang G; Hillyer CD; Mohandas N; Chen L; Sun L; An X
    J Hematol Oncol; 2018 Feb; 11(1):19. PubMed ID: 29433555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ineffective erythropoiesis in myelodysplastic syndrome].
    Iwama A
    Rinsho Ketsueki; 2018; 59(6):793-797. PubMed ID: 29973461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of SF3B1/DNMT3A Comutations With DNMT3A or SF3B1 Mutation Alone in Myelodysplastic Syndrome and Clonal Cytopenia of Undetermined Significance.
    Song J; Hussaini M; Qin D; Zhang X; Shao H; Zhang L; Gajzer D; Basra P; Moscinski L; Zhang H
    Am J Clin Pathol; 2020 Jun; 154(1):48-56. PubMed ID: 32112088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromes.
    Komrokji R; Volpe V; Chan O; Al Ali N; Swoboda D; Kuykendall A; Padron E; Sallman DA
    Blood; 2021 Sep; 138(11):989-992. PubMed ID: 34036300
    [No Abstract]   [Full Text] [Related]  

  • 8. A variant erythroferrone disrupts iron homeostasis in
    Bondu S; Alary AS; Lefèvre C; Houy A; Jung G; Lefebvre T; Rombaut D; Boussaid I; Bousta A; Guillonneau F; Perrier P; Alsafadi S; Wassef M; Margueron R; Rousseau A; Droin N; Cagnard N; Kaltenbach S; Winter S; Kubasch AS; Bouscary D; Santini V; Toma A; Hunault M; Stamatoullas A; Gyan E; Cluzeau T; Platzbecker U; Adès L; Puy H; Stern MH; Karim Z; Mayeux P; Nemeth E; Park S; Ganz T; Kautz L; Kosmider O; Fontenay M
    Sci Transl Med; 2019 Jul; 11(500):. PubMed ID: 31292266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SF3B1 mutant myelodysplastic syndrome: Recent advances.
    Pellagatti A; Boultwood J
    Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.
    Liberante FG; Lappin K; Barros EM; Vohhodina J; Grebien F; Savage KI; Mills KI
    Sci Rep; 2019 Feb; 9(1):2678. PubMed ID: 30804405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis.
    Tang Y; Miao M; Han S; Qi J; Wang H; Ruan C; Wu D; Han Y
    Crit Rev Oncol Hematol; 2019 Jan; 133():74-83. PubMed ID: 30661660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyserythropoiesis in myelodysplastic syndrome].
    Iwama A
    Rinsho Ketsueki; 2018; 59(10):2036-2041. PubMed ID: 30305506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of SF3B1 and SRSF2 Genes in Myelodysplastic Syndromes Patients in Upper Northern Thailand.
    Yimpak P; Tantiworawit A; Rattanathammethee T; Angsuchawan S; Laowatthanapong S; Tasuya W; Bumroongkit K
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1215-1221. PubMed ID: 31030497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications.
    Singh S; Ahmed D; Dolatshad H; Tatwavedi D; Schulze U; Sanchi A; Ryley S; Dhir A; Carpenter L; Watt SM; Roberts DJ; Abdel-Aal AM; Sayed SK; Mohamed SA; Schuh A; Vyas P; Killick S; Kotini AG; Papapetrou EP; Wiseman DH; Pellagatti A; Boultwood J
    Leukemia; 2020 Sep; 34(9):2525-2530. PubMed ID: 32076118
    [No Abstract]   [Full Text] [Related]  

  • 15. Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.
    Ambaglio I; Malcovati L; Papaemmanuil E; Laarakkers CM; Della Porta MG; Gallì A; Da Vià MC; Bono E; Ubezio M; Travaglino E; Albertini R; Campbell PJ; Swinkels DW; Cazzola M
    Haematologica; 2013 Mar; 98(3):420-3. PubMed ID: 23300182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ineffective erythropoiesis and its treatment.
    Cazzola M
    Blood; 2022 Apr; 139(16):2460-2470. PubMed ID: 34932791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDS with deletions in the long arm of chromosome 11 are associated with a high frequency of SF3B1 mutations.
    Stengel A; Kern W; Meggendorfer M; Haferlach T; Haferlach C
    Leukemia; 2017 Sep; 31(9):1995-1997. PubMed ID: 28592886
    [No Abstract]   [Full Text] [Related]  

  • 18.
    Mangaonkar AA; Lasho TL; Finke C; Ketterling RP; Reichard KK; McCullough K; Gangat N; Al-Kali A; Begna KH; Hogan WH; Litzow MR; Alkhateeb H; Shah M; Pardanani A; Tefferi A; Al Ali NH; Talati C; Sallman D; Padron E; Komrokji R; Patnaik MM
    Haematologica; 2022 May; 107(5):1189-1192. PubMed ID: 35142154
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q).
    Tefferi A; Idossa D; Lasho TL; Mudireddy M; Finke C; Shah S; Nicolosi M; Patnaik MM; Pardanani A; Gangat N; Hanson CA; Ketterling RP
    Blood Cancer J; 2017 Dec; 7(12):658. PubMed ID: 29249799
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter to the Editor regarding the article "Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis".
    Yang T; Wang L; Zhang Y
    Crit Rev Oncol Hematol; 2021 Jun; 162():103295. PubMed ID: 33992800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.